Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE)
Condition: Bladder Cancer Interventions: Drug: Cabozantinib; Drug: Atezolizumab; Procedure: Cystectomy Sponsors: Deepak Kilari; Exelixis; Genentech, Inc.; Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials